Blackstone-Backed Drug Tech Co. Raises $823M In IPO
The Blackstone Group LP-backed drug delivery company Catalent Inc. raised $822.7 million Thursday in its public debut, pricing in the middle of its range at $20.50 per share as it joined...To view the full article, register now.
Already a subscriber? Click here to view full article